jrnl9102

Publication Venue For

  • Performance of Noninvasive Assessment in the Diagnosis of Right Heart Failure After Left Ventricular Assist Device.  65:449-455. 2019
  • Use of computed tomography in preoperative planning for heartware left ventricular assist device placement.  65:70-76. 2019
  • Association of pulsatility with gastrointestinal bleeding in a cohort of HeartMate II recipients.  64:472-479. 2018
  • Anticoagulation control in patients with ventricular assist devices.  63:759-765. 2017
  • Automated rotational percussion bed and bronchoscopy improves respiratory mechanics and oxygenation in ARDS patients supported with extracorporeal membrane oxygenation.  62:e27-e29. 2016
  • Early implementation of video capsule enteroscopy in patients with left ventricular assist devices and obscure gastrointestinal bleeding.  62:40-45. 2016
  • Predictors of thromboembolic events in patients with ventricular assist device.  61:640-647. 2015
  • A nitric oxide-releasing self-assembled peptide amphiphile nanomatrix for improving the biocompatibility of microporous hollow fibers.  61:589-595. 2015
  • Use of ECMO in the management of severe acute respiratory distress syndrome: A survey of academic medical centers in the United States.  61:556-563. 2015
  • Predictors of Thromboembolic Events in Patients with Ventricular Assist Device 2015
  • Anti-Xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.  61:339-344. 2015
  • Feasibility Study of Particulate Extracellular Matrix (P-ECM) and Left Ventricular Assist Device (HVAD) Therapy in Chronic Ischemic Heart Failure Bovine Model.  61:161-169. 2015
  • Modern use of extracorporeal life support in pregnancy and postpartum.  61:110-114. 2015
  • Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.  61:107-109. 2015
  • Transhepatic Cannulation for Venovenous Extracorporeal Membrane Oxygenation.  61:e29-e30. 2015
  • Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantation.  59:480-485. 2013
  • Use of retrospectively gated CT angiography to diagnose systolic LVAD inflow obstruction.  59:542-546. 2013
  • The evolution of extracorporeal life support as a bridge to lung transplantation.  59:3-10. 2013
  • Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the seattle heart failure model.  58:93-97. 2012
  • Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.  57:32-37. 2011
  • B-Type natriuretic peptide levels and continuous-flow left ventricular assist devices.  56:527-531. 2010
  • Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle.  56:410-416. 2010
  • Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: Role of contact protein and tissue factor initiation.  55:33-40. 2009
  • Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.  54:578-584. 2008
  • Mechanical circulatory device thrombosis: A new paradigm linking hypercoagulation and hypofibrinolysis.  54:351-358. 2008
  • Managing device infections: Are we progressing or is infection an insurmountable obstacle?.  51:452-455. 2005
  • Serologic analysis of anti-porcine endogenous retroviruses immune responses in humans after ex vivo transgenic pig liver perfusion.  49:407-416. 2003
  • How to run an outpatient VAD program: Overview.  47:588-589. 2001
  • Infection with clinical ventricular assist devices: Clinical therapy.  47:195-196. 2001
  • Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices.  46:587-589. 2000
  • Fungal infections in ventricular assist devices.  46. 2000
  • Measurement of percent oxyhemoglobin by optical densitometry in perfluorocarbon supplemented blood.  42. 1996
  • High flux plasma exchange using a modified rotating membrane system.  42:957-960. 1996
  • Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist device.  41. 1995
  • Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.  41. 1995
  • Influence of longer term left ventricular assist device support on valvular regurgitation.  40. 1994
  • Perfluorocarbon oxygen transport: A comparative study of four oxygenator designs.  40. 1994